Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Preoperative Exercise in Pancreatic Cancer

The Effects of a Preoperative Exercise Intervention During Neoadjuvant Therapy in Patients With Pancreatic Cancer

Outcome
Results posted; single-arm, no comparison
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
10 May 2016
Ended
January 2021
Enrollment
3 participants
Sites
1
Primary outcomes
Change in 400-meter Walk Time
Sponsor type
Academic / other
Results posted
30 November 2021
Last update
30 November 2021

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Results

Primary endpoint
Results posted; single-arm, no comparisonAs posted on ClinicalTrials.gov ↗, registry record of 30 November 2021
Primary outcome
Change in 400-meter Walk TimeBaseline: Exercise Group: 212.7 (211 to 214), n = 3Pre-operative: Exercise Group: 194.3 (188 to 205), n = 3Postoperative: Exercise Group: 204 (195 to 213), n = 2Values: mean s, Full RangeTime frame: Baseline, Pre-operative (within the 2 weeks prior to surgery), 6 weeks postoperativeNo analysis posted for this outcome (outcome 1)
Participants
Exercise Group: 3 started, 3 completed
Serious adverse events
Exercise Group: 0 of 3Participants with at least one serious adverse event, of those at risk, as posted

Every value is copied from the trial’s results record at ClinicalTrials.gov. “Statistically significant” describes the posted test only: it does not say which group did better, and nothing here is read from a paper.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The purpose of this study is to investigate the effects of a preoperative exercise program in patients with pancreatic cancer preparing for surgery. Preoperative exercise programs have been shown to be effective in other cancer populations, but have not been investigated in patients with pancreatic cancer. The outcomes in this study will be changes in physical fitness, function, and postoperative outcomes. This investigation is a non-randomized control trial, with participants assigned to receive the preoperative exercise intervention in addition to standard care, or standard care alone if unable to commit to an exercise program for practical reasons. Possible mediators for the effects of exercise on postoperative outcomes will also be assessed, including psychological outcomes and markers of systemic inflammation. These measures will be assessed in all participants prior to program initiation, prior to surgery, and after surgery. Changes in these measures in response to exercise will be assessed, as well as the ability of the preoperative measures to predict postoperative outcomes.

Detailed description public domain (ClinicalTrials.gov)

This study focuses on patients prescribed neoadjuvant (preoperative chemotherapy and radiation) prior to surgery for borderline resectable pancreatic adenocarcinoma. This allows for a known, preoperative window long enough to provide an effective exercise intervention. The exercise program will be administered for at least eight weeks, but has no cap on length, as neoadjuvent treatment periods can vary between participants and a cessation of the exercise program before the end of this period could result in an undesirable loss in physical fitness and function. The study is a non-randomized, parallel group, intervention control trial, based on pilot studies in similar patient populations. All participants meeting the inclusion criteria and able to participate in the exercise program will be assigned to the exercise group. Participants meeting the inclusion criteria, but unable to commit to the exercise program for practical reasons (transportation, location, etc), will be assigned to the standard care group.

Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)

Change in 400-meter Walk Time [Baseline, Pre-operative (within the 2 weeks prior to surgery), 6 weeks postoperative]. Mean, s (Full Range). Baseline: Exercise Group (n=3): 212.7 (211 to 214). Pre-operative: Exercise Group (n=3): 194.3 (188 to 205). Postoperative: Exercise Group (n=3): 204 (195 to 213).